These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

757 related items for PubMed ID: 23079063

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group.
    Lübbert M, Suciu S, Baila L, Rüter BH, Platzbecker U, Giagounidis A, Selleslag D, Labar B, Germing U, Salih HR, Beeldens F, Muus P, Pflüger KH, Coens C, Hagemeijer A, Eckart Schaefer H, Ganser A, Aul C, de Witte T, Wijermans PW.
    J Clin Oncol; 2011 May 20; 29(15):1987-96. PubMed ID: 21483003
    [Abstract] [Full Text] [Related]

  • 23. Lack of objective response of myelodysplastic syndromes and acute myeloid leukemia to decitabine after failure of azacitidine.
    Duong VH, Bhatnagar B, Zandberg DP, Vannorsdall EJ, Tidwell ML, Chen Q, Baer MR.
    Leuk Lymphoma; 2015 Jun 20; 56(6):1718-22. PubMed ID: 25263320
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparison of Azacitidine and Decitabine in Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Network Meta-analysis.
    Liu W, Zhou Z, Chen L, Wang X.
    Clin Lymphoma Myeloma Leuk; 2021 Jun 20; 21(6):e530-e544. PubMed ID: 33716056
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Review of azacitidine trials in Intermediate-2-and High-risk myelodysplastic syndromes.
    Fenaux P, Ades L.
    Leuk Res; 2009 Dec 20; 33 Suppl 2():S7-11. PubMed ID: 20004796
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Decitabine in the treatment of myelodysplastic syndromes.
    Santos FP, Kantarjian H, Garcia-Manero G, Issa JP, Ravandi F.
    Expert Rev Anticancer Ther; 2010 Jan 20; 10(1):9-22. PubMed ID: 20014881
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Evidence for Selective Benefit of Sequential Treatment With Hypomethylating Agents in Patients With Myelodysplastic Syndrome.
    Apuri S, Al Ali N, Padron E, Lancet JE, List AF, Komrokji RS.
    Clin Lymphoma Myeloma Leuk; 2017 Apr 20; 17(4):211-214. PubMed ID: 28185797
    [Abstract] [Full Text] [Related]

  • 33. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
    Ferrara F.
    Hematol Oncol; 2014 Mar 20; 32(1):1-9. PubMed ID: 23512815
    [Abstract] [Full Text] [Related]

  • 34. The role of hypomethylating agents in myelodysplastic syndrome: changing the management paradigm.
    Merkel DG, Nagler A.
    Expert Rev Hematol; 2013 Dec 20; 6(6):665-76. PubMed ID: 24191866
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromes.
    Klimek VM, Dolezal EK, Tees MT, Devlin SM, Stein K, Romero A, Nimer SD.
    Leuk Res; 2012 Sep 20; 36(9):1093-7. PubMed ID: 22608310
    [Abstract] [Full Text] [Related]

  • 38. Decitabine.
    Daskalakis M, Blagitko-Dorfs N, Hackanson B.
    Recent Results Cancer Res; 2010 Sep 20; 184():131-57. PubMed ID: 20072836
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The role of decitabine in the treatment of myelodysplastic syndromes.
    Atallah E, Kantarjian H, Garcia-Manero G.
    Expert Opin Pharmacother; 2007 Jan 20; 8(1):65-73. PubMed ID: 17163808
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.